🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Investigational Treatment Acquiring Traction Online

The experimental drug, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning properties. Viewers are urged to contact these profiles directly for supplier links, while also obtaining promotional offers.

Active Trade on Messaging Platforms

Additionally, a flourishing trade exists on Telegram, where groups with thousands of participants share “before and after” images, injection guides and claims of next-day British shipping. Sellers market the substance there before directing buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the successor to Ozempic.

Healthcare Professionals Voice Concerns

Nevertheless, physicians and pharmacists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.

Some experts said the demand for retatrutide could be linked to the rising cost of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed drug that cannot be promoted or supplied for personal consumption under the British medical regulations.

Some influencers attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled drug, but promotion and distribution can still violate pharmaceutical, marketing, and consumer regulations, risking penalties, legal action or prison.

Service Response and Content Elimination

According to the social media company, the platform has taken down violative content and banned related keywords and query recommendations. The organization said it was dedicated to keeping the service safe and investing in enhancing compliance measures.

Online Marketplace Activities

Research also found groups with up to nine thousand members selling retatrutide using Telegram's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up groups with thousands of users, filled with images of weight loss, glowing reviews and detailed instructions for mixing or injecting at residence.

Within minutes of joining one community, a seller posted WhatsApp details, where the majority of purchases take place. The vendor provided an guidebook and guaranteed shipping within 48 hours. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None inquired about body mass, health issues or past usage.

Item Details and Pricing

Inside these groups, messages display dark colored parcels with Royal Mail stickers, stating to include new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at residence with sterile water, or ready-to-use pens usually priced at 160 pounds for 20mg. When asked how much time a injector should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Service Oversight and Security Measures

A representative for the messaging service stated it regularly moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“People are administering substances they cannot confirm. Even if the research behind retatrutide is sound, these online products may not include what they advertise,” stated Jason Murphy, the head of pharmacy at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor linked the increase in interest to recent price rises for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit injections are highly risky. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.

Her team has previously seen individuals injured by self-injection from unverified sources. “We understand the frustration, but purchasing from messaging apps or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A representative from the pharmaceutical company stated the substance was in phase 3 research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject users to potentially serious health risks”.